Lunsumio Drug Interactions: 177 Major, 67 Moderate
Lunsumio (Mosunetuzumab) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Lunsumio. Always confirm against the full prescribing information.
100 interactions
Allopurinol
The risk or severity of adverse effects can be increased when Allopurinol is combined with Mosunetuzumab.
Level 1 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Mosunetuzumab.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Mosunetuzumab is combined with Articaine.
Level 1 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Mosunetuzumab.
Level 2 evidence
Benzocaine
The risk or severity of methemoglobinemia can be increased when Mosunetuzumab is combined with Benzocaine.
Level 1 evidence
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Mosunetuzumab is combined with Benzyl alcohol.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Mosunetuzumab.
Level 2 evidence
Bupivacaine
The risk or severity of methemoglobinemia can be increased when Mosunetuzumab is combined with Bupivacaine.
Level 1 evidence
Butamben
The risk or severity of methemoglobinemia can be increased when Mosunetuzumab is combined with Butamben.
Level 1 evidence
Capsaicin
The risk or severity of methemoglobinemia can be increased when Mosunetuzumab is combined with Capsaicin.
Level 1 evidence
Abemaciclib
The metabolism of Abemaciclib can be decreased when combined with Mosunetuzumab.
Level 1 evidence
Acalabrutinib
The metabolism of Acalabrutinib can be decreased when combined with Mosunetuzumab.
Level 1 evidence
Enter your NPI to unlock 34 major interactions for Lunsumio
Lunsumio (Mosunetuzumab) has 522 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Lunsumio (Mosunetuzumab) has 177 major, 67 moderate, and 278 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Lunsumio. Always confirm against the full prescribing information.